Literature DB >> 3090879

Significance of isolation of Aspergillus from the respiratory tract in diagnosis of invasive pulmonary aspergillosis. Results from a three-year prospective study.

V L Yu, R R Muder, A Poorsattar.   

Abstract

The isolation of Aspergillus species from respiratory secretions has been regarded as being of limited usefulness in the antemortem diagnosis of invasive pulmonary aspergillosis. One hundred and eight consecutive patients were evaluated in whom Aspergillus species were isolated from respiratory secretions. Invasive aspergillosis was not demonstrated in non-immunosuppressed patients or in patients with solid tumors in the absence of neutropenia. Lung tissue was examined in 17 patients with leukemia and/or neutropenia; all had invasive aspergillosis. Tissue examination was not performed in 20 neutropenic patients; of 17 not receiving antifungal therapy, 16 died. Multivariate statistical analysis showed that neutropenia and absence of cigarette smoking were significant predictors of invasive aspergillosis in patients with respiratory tract cultures yielding Aspergillus. All cases of invasive aspergillosis were associated with A. fumigatus or A. flavus. The isolation of A. fumigatus or A. flavus from the respiratory tract of a patient with leukemia and/or neutropenia is highly predictive of invasive infection. Empiric amphotericin B therapy, without the necessity for tissue diagnosis, should be considered in this patient subgroup.

Entities:  

Mesh:

Year:  1986        PMID: 3090879     DOI: 10.1016/0002-9343(86)90259-7

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  45 in total

Review 1.  A persistent challenge: the diagnosis of respiratory disease in the non-AIDS immunocompromised host.

Authors:  C Mayaud; J Cadranel
Journal:  Thorax       Date:  2000-06       Impact factor: 9.139

2.  Thyrotoxicosis induced by thyroid involvement of disseminated Aspergillus fumigatus infection.

Authors:  M W Hornef; J Schopohl; C Zietz; K K Hallfeldt; A Roggenkamp; R Gärtner; J Heesemann
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

3.  Invasive pulmonary aspergillosis in non-immunocompromised patients.

Authors:  J L Hovenden; F Nicklason; R A Barnes
Journal:  BMJ       Date:  1991-03-09

4.  Polymerase chain reaction screening for fungemia and/or invasive fungal infections in patients with hematologic malignancies.

Authors:  Patrícia Ribeiro; Fátima Costa; Alexandra Monteiro; Joana Caldas; Madalena Silva; Gilda Ferreira; Joana Veiga; Manuel O Sousa; Maria P Viegas; Ester Santos; António J Gonçalves; Aida B Sousa
Journal:  Support Care Cancer       Date:  2006-01-25       Impact factor: 3.603

Review 5.  Diagnosing fungal infections in immunocompromised hosts.

Authors:  C M Tang; J Cohen
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

6.  Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease.

Authors:  L B Palmer; H E Greenberg; M J Schiff
Journal:  Thorax       Date:  1991-01       Impact factor: 9.139

Review 7.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

8.  Molecular typing of environmental and patient isolates of Aspergillus fumigatus from various hospital settings.

Authors:  V Chazalet; J P Debeaupuis; J Sarfati; J Lortholary; P Ribaud; P Shah; M Cornet; H Vu Thien; E Gluckman; G Brücker; J P Latgé
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Detection of sputum Aspergillus galactomannan for diagnosis of invasive pulmonary aspergillosis in haematological patients.

Authors:  Shun-Ichi Kimura; Jun Odawara; Takatoshi Aoki; Masayuki Yamakura; Masami Takeuchi; Kosei Matsue
Journal:  Int J Hematol       Date:  2009-10-20       Impact factor: 2.490

10.  Dose-dependent antifungal activity and nephrotoxicity of amphotericin B colloidal dispersion in experimental pulmonary aspergillosis.

Authors:  M C Allende; J W Lee; P Francis; K Garrett; H Dollenberg; J Berenguer; C A Lyman; P A Pizzo; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1994-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.